20 June 2013
Keywords: forest, richter, report, bipolar, trial, usa-based, pharmaceutical
Article | 06 October 2008
USA-based pharmaceutical company Forest Laboratories and Hungarian drugmaker Richter Gedeon reported preliminary top-line results from a Phase II study of ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.